14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ACIU
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

AC Immune SA stock price ended at $2.39 on Friday, after losing 2.05%.
(Updated on May 03, 2024)

Sell candidate since Mar 20, 2024 Loss -26.57% PDF

The AC Immune SA stock price fell by -2.05% on the last day (Friday, 3rd May 2024) from $2.44 to $2.39. During the last trading day the stock fluctuated 3.38% from a day low at $2.37 to a day high of $2.45. The price has been going up and down for this period, and there has been a 1.27% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -8 thousand shares and in total, 117 thousand shares were bought and sold for approximately $278.86 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.19 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -23.38% during the next 3 months and, with a 90% probability hold a price between $1.68 and $2.51 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ACIU Signals & Forecast

There are mixed signals in the stock today. The AC Immune SA stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.41 and $2.72. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 4.37%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for AC Immune SA stock

AC Immune SA finds support from accumulated volume at $2.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0800 between high and low, or 3.38%. For the last week the stock has had daily average volatility of 5.52%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ACIU) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect AC Immune SA to open at $2.40, and during the day (based on 14 day Average True Range), to move between $2.21 and $2.57, which gives a possible trading interval of +/-$0.180 (+/-7.53%) up or down from last closing price. If AC Immune SA takes out the full calculated possible swing range there will be an estimated 15.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.38 (0.42%) than the resistance at $2.80 (17.15%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is AC Immune SA stock A Buy?

AC Immune SA holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.455 Sell Candidate Unchanged

Predicted Opening Price for AC Immune SA of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
$2.40 ( 0.558%) $2.39

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ACIU

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.48 3.91 %
R2 2.45 2.63 %
R1 2.43 1.84 %
Current price: 2.39
Support S1 2.37 -0.721 %
S2 2.35 -1.51 %
S3 2.32 -2.79 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.90 21.34 %
R2 2.84 18.83 %
R1 2.80 17.15 %
Current price 2.39
Support S1 2.38 -0.418%
S2 2.37 -0.84%
S3 2.29 -4.18%

FAQ

What is the symbol for AC Immune SA Stock and on which exchange is it traded?
The symbol for AC Immune SA is ACIU and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell AC Immune SA Stock?
AC Immune SA holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy AC Immune SA Stock?
AC Immune SA Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AC Immune SA Stock.

What's the current price of AC Immune SA Stock?
As of the end of day on the May 03, 2024, the price of an AC Immune SA (ACIU) share was $2.39.

What is the 52-week high and low for AC Immune SA Stock?
The 52-week high for AC Immune SA Stock is $5.13 and the 52-week low is $1.78.

What is the market capitalization of AC Immune SA Stock?
As of the May 03, 2024, the market capitalization of AC Immune SA is 242.043M.

When is the next earnings date for AC Immune SA?
The upcoming earnings date for AC Immune SA is Aug 02, 2024.
Click to get the best stock tips daily for free!

About AC Immune SA

AC Immune SA AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. The comp... ACIU Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT